ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IPH Innate Pharma

2,40
0,05 (2,13%)
23 Fev 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Innate Pharma IPH Euronext Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,05 2,13% 2,40 13:40:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,325 2,325 2,44 2,40 2,35
mais cotações »

Notícias Recentes

Data Hora Fonte Título
21/02/202403:00BWInnate Pharma annonce sa participation a une prochaine..
12/01/202403:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
04/01/202403:00BWInnate Pharma Announces U.S. FDA Lifts Partial Clinical Hold..
04/01/202402:59BWInnate Pharma renforce son équipe de direction et nomme deux..
19/12/202309:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
19/12/202303:00BWInnate Pharma annonce la licence d’un quatrième NK Cell..
18/12/202303:00BWInnate Pharma annonce un changement de direction
11/12/202303:00BWInnate Pharma partage les résultats d’efficacité et de..
10/12/202303:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
27/11/202303:00BWInnate Pharma to Host Virtual KOL Event on Lacutamab
14/11/202303:00BWInnate Pharma présente ses résultats financiers au troisième..
07/11/202303:00BWInnate Pharma organise une conférence téléphonique pour ses..
03/11/202303:00BWInnate Pharma Announces New Clinical Data for Lacutamab and..
27/10/202302:00BWInnate Pharma Announces Its Participation to Upcoming..
19/10/202302:00BWInnate Pharma 2024 Financial Calendar
16/10/202302:00BWInnate Pharma Announces Abstracts Selected for ESMO Congress..
09/10/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
05/10/202309:14DJNInnate Pharma Shares Fall Premarket on FDA Partial Study..
05/10/202302:00BWInnate Pharma Provides Update on Lacutamab Clinical Program
22/09/202302:00BWInnate Pharma Announces Encore Presentation of Interim..
14/09/202302:00BWInnate Pharma présente ses résultats financiers et l’avancée..
29/08/202302:00BWInnate Pharma annonce sa participation à de prochaines..
10/08/202302:00BWProchain rendez-vous investisseurs d'Innate Pharma
11/07/202302:00BWPremier patient traité dans l'essai clinique de Phase 1/2..
07/07/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
26/06/202302:00BWInnate Pharma: First Patient Dosed in Phase 2 MATISSE Trial..
16/06/202302:00BWInnate Pharma Highlights Increased Lacutamab Clinical..
12/06/202302:00BWInnate Pharma to Present Updated Interim Phase 2 Efficacy..
10/06/202302:00BWInnate Pharma présente IPH6501, son NK Cell Engager ANKET®..
08/06/202311:53DJNInnate Pharma Shares Rise 8% After Cancer Treatment Gets..
08/06/202302:00BWSAR’579 / IPH6101 Receives FDA Fast Track Designation in the..
07/06/202302:00BWNouveau nombre d’actions et de droits de vote d’Innate..
26/05/202302:00BWInnate Pharma Highlights Phase 1/2 Dose Escalation Safety..
23/05/202302:00BWInnate Pharma to Participate in Upcoming Investor..
15/05/202302:00BWInnate Pharma présentera des données précliniques pour..
12/05/202317:00BWOutcome of Innate Pharma’s 2023 Annual General Meeting
10/05/202302:00BWInnate Pharma : information financiere du premier trimestre..
09/05/202302:00BWNumber of shares and voting rights of Innate Pharma as of..
03/05/202302:00BWInnate Pharma Highlights Clinical Abstracts Selected for..
26/04/202317:50BWInnate Pharma met en place un nouveau programme..
21/04/202302:00BWProchain rendez-vous investisseurs d'Innate Pharma
18/04/202302:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
07/04/202302:00BWInnate Pharma to Hold Its Annual General Meeting of..
06/04/202302:00BWInnate Pharma publie son document d’enregistrement universel..
03/04/202302:00BWInnate Pharma Announces Exclusive License of Antibodies to..
23/03/202303:00BWInnate Pharma Reports Full Year 2022(1) Financial Results..
20/03/202303:00BWNouveau nombre d’actions et de droits de vote d’Innate..
16/03/202303:00BWInnate Pharma Announces Conference Call and Webcast for Full..
13/03/202303:00BWInnate Pharma Provides Update on Silicon Valley Bank..

Seu Histórico Recente

Delayed Upgrade Clock

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

Support: (11) 4950 5808 | suporte@advfn.com.br